Specify a stock or a cryptocurrency in the search bar to get a summary
FDC Limited
FDCFDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Vitcofol, Ziglim, Ziglim Plus 2, Electral, and Enerzal brand names. The company was founded in 1936 and is headquartered in Mumbai, India. Address: C/3, Skyvistas, Mumbai, India, 400053
Analytics
WallStreet Target Price
29 550.62 INRP/E ratio
26.3795Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures FDC
Dividend Analytics FDC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
6 %Dividend History FDC
Stock Valuation FDC
Financials FDC
Results | 2019 | Dynamics |